Molecular Templates, Inc. — Operating Income by Fiscal Year

15 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/aea4a02c-f3a5-45e4-b6fa-7ec1b9d7a980/serie/operating-income

Fiscal year	Operating Income	Period	Evidence
FY 2023	$-10.5M	2023-01-01 – 2023-12-31	evidence 0001558370-24-004332
FY 2022	$-88.9M	2022-01-01 – 2022-12-31	evidence 0001564590-23-004898
FY 2021	$-80.1M	2021-01-01 – 2021-12-31	evidence 0001564590-22-012055
FY 2020	$-100.8M	2020-01-01 – 2020-12-31	evidence 0001564590-21-014250
FY 2019	$-70.4M	2019-01-01 – 2019-12-31	evidence 0001564590-20-010667
FY 2018	$-31.0M	2018-01-01 – 2018-12-31	evidence 0001564590-19-010145
FY 2017	$-17.8M	2017-01-01 – 2017-12-31	evidence 0001564590-18-007268
FY 2016	$-10.6M	2016-01-01 – 2016-12-31	evidence 0001564590-18-007268
FY 2015	$26.9M	2015-01-01 – 2015-12-31	evidence 0001564590-16-014457
FY 2014	$-31.3M	2014-01-01 – 2014-12-31	evidence 0001564590-15-001251
FY 2013	$-26.0M	2013-01-01 – 2013-12-31	evidence 0001193125-14-085581
FY 2012	$-20.0M	2012-01-01 – 2012-12-31	evidence 0001193125-13-095969
FY 2011	$-267.2M	2001-10-17 – 2011-12-31	evidence 0001193125-12-117619
FY 2010	$-23.9M	2010-01-01 – 2010-12-31	evidence 0001193125-12-117619
FY 2009	$-21.3M	2009-01-01 – 2009-12-31	evidence 0001193125-12-117619

Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

Molecular Templates, Inc. — all facts · Revenue · Net Income